3-year follow-up of checkmate 649: nivolumab chemotherapy in gc/gejc/eac
Published 1 year ago • 342 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:44
checkmate 649: nivolumab and chemotherapy or ipilimumab in gc/gejc/eac
-
6:23
checkmate 649 3-year follow-up: nivolumab plus chemotherapy for gastric and esophageal cancers
-
2:26
nivo chemo vs chemo as 1l treatment for advanced gc/gejc/eac: 4 year yr follow-up of checkmate 649
-
6:31
checkmate 649 biomarker analyses of nivo ipi vs chemo for patients with gc/gejc/eac
-
4:43
biomarker analyses of the checkmate 649 trial in gc/gejc/eac
-
6:54
checkmate 649: 1l nivo chemotherapy improves os
-
8:38
checkmate 459: nivolumab plus chemotherapy for gc / gejc / eac
-
4:47
nivolumab chemotherapy combination treatment: checkmate649 and attraction-4
-
3:19
geoffrey y. ku, md, offers opinion on the practice-changing potential of the checkmate-649 study
-
1:19
29-month follow-up from checkmate 648: nivolumab combination therapy in escc
-
5:22
checkmate 743: first-line nivolumab plus ipilimumab vs chemotherapy in patients with unresectabl...
-
4:21
rationale and study design of checkmate-649 biomarker analysis
-
1:48
checkmate 205: 5 year follow-up of nivolumab in hl
-
3:41
highlights in gastric cancer from esmo 2021
-
2:28
jaffer ajani, md, considers results from the checkmate 649 study presented at esmo 2020
-
7:12
part 2 - nivolumab with chemotherapy in advanced previously untreated gastric - dr. anant ramaswamy
-
1:01
long-term efficacy of nivolumab combinations in advanced escc in checkmate 648
-
4:51
expanded efficacy and safety analyses from checkmate 648
-
5:18
checkmate577: nivolumab in ec/gejc